The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
Sindelfingen-Boebblingen Medical Center
Country
Germany
Current Status, Position
Dr Andreas von Ameln-Mayerhofer is currently a Hospital Pharmacist at the Sindelfingen-Boebblingen Medical Center. He is responsible of clinical pharmacy activities, i.e. patient services.
Education
Dr Andreas von Ameln-Mayerhofer studied pharmacy at Freiburg University (Germany) and became a licensed pharmacist in 1996. In 2003, he finished his doctoral thesis at Tuebingen University, in the neuropharmacology and pharmaceutical chemistry departments. The focus of his scientific work was on the neupharmacology of dopamine and serotonin. In 2011, he started specialising on clinical pharmacy, antimicrobial stewardship and infectiology.
Research Area
Dr von Ameln-Mayerhofer’s research focuses on neuropsychopharmacology, clinical and renal pharmacy and infectiology. He is mainly interested in the therapeutic drug monitoring anti-infectives.
Conflict of interest: none